» Articles » PMID: 39292271

The Protective Role of RACK1 in Hepatic Ischemia‒reperfusion Injury-induced Ferroptosis

Overview
Journal Inflamm Res
Date 2024 Sep 18
PMID 39292271
Authors
Affiliations
Soon will be listed here.
Abstract

Although ferroptosis plays a crucial role in hepatic ischemia‒reperfusion injury (IRI), the molecular mechanisms underlying this process remain unclear. We aimed to explore the potential involvement of the receptor for activated C kinase 1 (RACK1) in hepatic IRI-triggered ferroptosis. Using hepatocyte-specific RACK1 knockout mice and alpha mouse liver 12 (AML12) cells, we conducted a series of in vivo and in vitro experiments. We found that RACK1 has a protective effect on hepatic IRI-induced ferroptosis. Specifically, RACK1 was found to interact with AMPKα through its 1-93 amino acid (aa) region, which facilitates the phosphorylation of AMPKα at threonine 172 (Thr172), ultimately exerting an antiferroptotic effect. Furthermore, the long noncoding RNA (lncRNA) ZNFX1 Antisense 1 (ZFAS1) directly binds to aa 181-317 of RACK1. ZFAS1 has a dual impact on RACK1 by promoting its ubiquitin‒proteasome-mediated degradation and inhibiting its expression at the transcriptional level, which indirectly exacerbates hepatic IRI-induced ferroptosis. These findings underscore the protective role of RACK1 in hepatic IRI-induced ferroptosis and showcase its potential as a prophylactic target for hepatic IRI mitigation.

Citing Articles

The role of ferroptosis-related non-coding RNA in liver fibrosis.

Zhang G, Wu K, Jiang X, Gao Y, Ding D, Wang H Front Cell Dev Biol. 2024; 12:1517401.

PMID: 39717848 PMC: 11663870. DOI: 10.3389/fcell.2024.1517401.

References
1.
Ni D, Wei H, Chen W, Bao Q, Rosenkrans Z, Barnhart T . Ceria Nanoparticles Meet Hepatic Ischemia-Reperfusion Injury: The Perfect Imperfection. Adv Mater. 2019; 31(40):e1902956. PMC: 6773480. DOI: 10.1002/adma.201902956. View

2.
Du Y, Guo W, Han C, Wang Y, Chen X, Li D . N6-methyladenosine demethylase FTO impairs hepatic ischemia-reperfusion injury via inhibiting Drp1-mediated mitochondrial fragmentation. Cell Death Dis. 2021; 12(5):442. PMC: 8096847. DOI: 10.1038/s41419-021-03622-x. View

3.
Huang J, Xie P, Dong Y, An W . Inhibition of Drp1 SUMOylation by ALR protects the liver from ischemia-reperfusion injury. Cell Death Differ. 2020; 28(4):1174-1192. PMC: 8027887. DOI: 10.1038/s41418-020-00641-7. View

4.
Bavarsad K, Riahi M, Saadat S, Barreto G, Atkin S, Sahebkar A . Protective effects of curcumin against ischemia-reperfusion injury in the liver. Pharmacol Res. 2018; 141:53-62. DOI: 10.1016/j.phrs.2018.12.014. View

5.
Selzner N, Rudiger H, Graf R, Clavien P . Protective strategies against ischemic injury of the liver. Gastroenterology. 2003; 125(3):917-36. DOI: 10.1016/s0016-5085(03)01048-5. View